181 related articles for article (PubMed ID: 11715626)
21. [Indications for the use of platelets, plasma and anti-hemorrhagic drugs].
Mateo J; Muñiz-Díaz E; Fontcuberta J; Madoz P
Rev Esp Anestesiol Reanim; 1992; 39(6):355-61. PubMed ID: 1293653
[TBL] [Abstract][Full Text] [Related]
22. Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donation.
Wurnig C; Schatz K; Noske H; Hemon Y; Dahlberg G; Josefsson G; Milbrink J; Hamard C;
Eur Surg Res; 2001; 33(5-6):303-10. PubMed ID: 11805389
[TBL] [Abstract][Full Text] [Related]
23. [Legal framework for the use of autologous blood and other alternatives to allogenic transfusion].
Muñoz M; García-Erce JA; Campos A; Fernando Barrios L
Med Clin (Barc); 2007 Feb; 128(7):256-62. PubMed ID: 17335739
[No Abstract] [Full Text] [Related]
24. Critical evaluation of blood-saving measures for high-risk patients.
Hartmann T; Winkler M; Preis C; Germann P; Donner A; Müller C
Acta Anaesthesiol Scand Suppl; 1997; 111():207-9. PubMed ID: 9421015
[No Abstract] [Full Text] [Related]
25. Acute preoperative hemodilution in surgical patients.
Klövekorn WP; Pichlmaier H; Ott E; Bauer H; Sunder-Plassmann L; Jesch F; Messmer K
Bibl Haematol; 1975; (41):248-59. PubMed ID: 1180832
[No Abstract] [Full Text] [Related]
26. Minimizing perioperative homologous blood exposure with recombinant human erythropoietin.
Levine EA; Gould SA
Surg Annu; 1993; 25 Pt 1():83-99. PubMed ID: 8416148
[TBL] [Abstract][Full Text] [Related]
27. [Erythrocytapheresis a few weeks before surgery: an alternative to erythropoietin treatment in programmed autologous transfusion].
Bernière J; Gerota I
Cah Anesthesiol; 1996; 44(4):303-8. PubMed ID: 9033827
[TBL] [Abstract][Full Text] [Related]
28. Intraoperative autologous blood salvage with cardiac surgery: an analysis of five years' experience in more than 3,000 patients.
Ikeda S; Johnston MF; Yagi K; Gillespie KN; Schweiss JF; Homan SM
J Clin Anesth; 1992; 4(5):359-66. PubMed ID: 1389188
[TBL] [Abstract][Full Text] [Related]
29. [Methods of preoperative hemodilution to reduce homologous blood transfusion].
Fukuda I
Nihon Rinsho; 1997 Sep; 55(9):2411-6. PubMed ID: 9301309
[TBL] [Abstract][Full Text] [Related]
30. [Effect of preoperative treatment with recombinant human erythropoietin in patients undergoing hemodilutional autologous transfusion].
Nakae Y; Sonoda H; Miyabe M; Kawamata M; Sakakibara N; Kawana S; Namiki A
Masui; 1995 Oct; 44(10):1362-8. PubMed ID: 8538004
[TBL] [Abstract][Full Text] [Related]
31. Trauma, Time, and Transfusions: A Longitudinal Analysis of Coagulation Markers in Severely Injured Trauma Patients Receiving Modified Whole Blood or Component Blood Products.
Rahbar E; Cardenas JC; Matijevic N; Del Junco D; Podbielski J; Cohen MJ; Cotton BA; Holcomb JB; Wade CE;
Shock; 2015 Nov; 44(5):417-25. PubMed ID: 26263433
[TBL] [Abstract][Full Text] [Related]
32. The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery.
Menges T; Welters I; Wagner RM; Boldt J; Dapper F; Hempelmann G
Eur J Cardiothorac Surg; 1997 Mar; 11(3):557-63. PubMed ID: 9105824
[TBL] [Abstract][Full Text] [Related]
33. [Role of autologous transfusion in economy measures for blood in surgery].
Janvier G; Bénillan N; Roth C
Nouv Rev Fr Hematol (1978); 1995; 37 Suppl 1():S5-7. PubMed ID: 7478984
[No Abstract] [Full Text] [Related]
34. Massive Transfusion in Children.
Karam O; Tucci M
Transfus Med Rev; 2016 Oct; 30(4):213-6. PubMed ID: 27287298
[TBL] [Abstract][Full Text] [Related]
35. The effect of pre-operative blood withdrawal, with or without sequestration, on allogeneic blood product requirements.
van der Wal MT; Boks RH; Wijers-Hille MJ; Hofland J; Takkenberg JJ; Bogers AJ
Perfusion; 2015 Nov; 30(8):643-9. PubMed ID: 25713053
[TBL] [Abstract][Full Text] [Related]
36. Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. International Study of Peri-operative Transfusion (ISPOT) Investigators.
Fergusson D; Blair A; Henry D; Hisashige A; Huet C; Koopman-van Gemert A; Katz E; McClelland B; Sigmund H; Laupacis A
Int J Technol Assess Health Care; 1999; 15(4):717-28. PubMed ID: 10645113
[TBL] [Abstract][Full Text] [Related]
37. [Administration of erythrocytes for the compensation of surgical blood loss in adults].
Ann Chir; 1995; 49(2):193-8. PubMed ID: 7793839
[No Abstract] [Full Text] [Related]
38. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage.
Diprose P; Herbertson MJ; O'Shaughnessy D; Deakin CD; Gill RS
Br J Anaesth; 2005 Mar; 94(3):271-8. PubMed ID: 15591329
[TBL] [Abstract][Full Text] [Related]
39. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
[TBL] [Abstract][Full Text] [Related]
40. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients.
Holcomb JB; Wade CE; Michalek JE; Chisholm GB; Zarzabal LA; Schreiber MA; Gonzalez EA; Pomper GJ; Perkins JG; Spinella PC; Williams KL; Park MS
Ann Surg; 2008 Sep; 248(3):447-58. PubMed ID: 18791365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
